Michael Barbella, Managing Editor03.26.24
Envoy Medical Inc. has been awarded three patents—two from U.S. authorities and one from European officials.
The patents are as follows:
Headquartered in White Bear Lake, Minn., Envoy Medical develops hearing-related technologies. Its fully implanted Acclaim Cochlear Implant features a sensor designed to leverage the ear's natural anatomy rather than a microphone to capture sound. Intended to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids, the Acclaim Cochlear Implant received U.S. Food and Drug Administration Breakthrough Device Designation in 2019.
The fully implanted Acclaim Cochlear Implant is an investigational device.
The patents are as follows:
- U.S. Patent No. 11,839,765: "Cochlear Implant System with Integrated Signal Analysis Functionality."
- US Patent No. 11,865,339: "Cochlear Implant System with Electrode Impedance Diagnostics."
- European Patent No. 3927420: "Implantable Cochlear System with Integrated Components and Lead Characterization."
Headquartered in White Bear Lake, Minn., Envoy Medical develops hearing-related technologies. Its fully implanted Acclaim Cochlear Implant features a sensor designed to leverage the ear's natural anatomy rather than a microphone to capture sound. Intended to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids, the Acclaim Cochlear Implant received U.S. Food and Drug Administration Breakthrough Device Designation in 2019.
The fully implanted Acclaim Cochlear Implant is an investigational device.